Encapsulated lactiplantibacillus plantarum improves Alzheimer’s symptoms in APP/PS1 mice
Open Access
- 20 September 2024
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 22 (1) , 1-19
Abstract
Alzheimer’s disease (AD) is a neurodegenerative disorder that can result in neurotoxicity and an imbalance in gut microbiota. Probiotics have been shown to play an important role in regulating the gut microbiota, but their viability and bioactivity are often compromised as they traverse the gastrointestinal tract, thereby reducing their efficacy and limiting their clinical utility. In this work, layer-by-layer (LbL) encapsulation technology was used to encapsulate Lactiplantibacillus plantarum (LP) to improve the above shortcomings. Studies in APPswe/PS1dE9 (APP/PS1) transgenic mice show that LbL-encapsulated LP ((CS/SP)2-LP) protects LP from gastrointestinal damage while (CS/SP)2-LP treatment It improves brain neuroinflammation and neuronal damage in AD mice, reduces Aβ deposition, improves tau protein phosphorylation levels, and restores intestinal barrier damage in AD mice. In addition, post-synaptic density protein 95 (PSD-95) expression increased in AD mice after treatment, indicating enhanced synaptic plasticity. Fecal metabolomic and microbiological analyzes showed that the disordered intestinal microbiota composition of AD mice was restored and short-chain fatty acids (SCFAs) levels were significantly increased after (CS/SP)2-LP treatment. Overall, the above evidence suggests that (CS/SP)2-LP can improve AD symptoms by restoring the balance of intestinal microbiota, and (CS/SP)2-LP treatment will provide a new method to improve the symptoms of AD patients.Keywords
Funding Information
- Natural Science Foundation of Shaanxi Province (2023-JC-YB-290)
- National Natural Science Foundation of China (81803491)
- Shaanxi Provincial Key R&D Program (2021SF-106)
- China Postdoctoral Science Foundation (2021M702633)
This publication has 45 references indexed in Scilit:
- Enhanced viability of layer-by-layer encapsulated Lactobacillus pentosus using chitosan and sodium phytateFood Chemistry, 2019
- Nondigestible carbohydrates, butyrate, and butyrate-producing bacteriaCritical Reviews in Food Science and Nutrition, 2018
- The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer’s Disease—a Critical ReviewMolecular Neurobiology, 2018
- Gut microbiota fermentation of marine polysaccharides and its effects on intestinal ecology: An overviewCarbohydrate Polymers, 2018
- The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?npj Parkinson's Disease, 2017
- Layer‐by‐Layer Encapsulation of Probiotics for Delivery to the MicrobiomeAdvanced Materials, 2016
- Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypesJournal of Clinical Investigation, 2012
- Microbiota restoration: natural and supplemented recovery of human microbial communitiesNature Reviews Microbiology, 2010
- The expression of glutamate transporters in chest compression-induced audiogenic epilepsy: a comparative studyNeurological Research, 2008
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memoryNature Medicine, 2008